Insider · CIK 0001892943
Eric Joseph Daniels
officer
Files at KPRX (KIORA PHARMACEUTICALS INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | KPRX KIORA PHARMACEUTICALS INC | AGrant or award Common Stock | +6,533 | $0.00 | $0 | 32,670 | Mar 10, 2026 |
| Mar 6, 2026 | KPRX KIORA PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +13,067 | $0.00 | $0 | 13,067 | Mar 10, 2026 |
| Mar 3, 2026 | KPRX KIORA PHARMACEUTICALS INC | FTax withholding Common Stock | -238 | $2.02 | $481 | 26,137 | Mar 6, 2026 |
| Apr 1, 2025 | KPRX KIORA PHARMACEUTICALS INC | AGrant or award Common Stock | +7,772 | $0.00 | $0 | 26,375 | Apr 2, 2025 |
| Apr 1, 2025 | KPRX KIORA PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +15,543 | $0.00 | $0 | 15,543 | Apr 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.